Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Eastman Chemical Company (EMN) SEC filings page provides access to the company’s regulatory disclosures as a public issuer on the New York Stock Exchange. As a global specialty materials company in the plastics material and resin manufacturing industry, Eastman files periodic and current reports that describe its financial condition, results of operations, governance matters, and material events.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q, which include segment information, discussions of end-market demand in areas such as transportation, building and construction, and consumables, and commentary on topics like cash generation, cost structure, and specialty materials performance. Current reports on Form 8-K provide timely updates on specific events, including quarterly earnings releases, Board and executive changes, and other matters the company deems material.
Investors can also review proxy statements for information on Board composition, committee assignments, and director compensation, as well as filings related to executive compensation and governance. For those monitoring insider activity, Forms 3, 4, and 5 disclose transactions by directors and officers in Eastman’s common stock.
On this page, AI-powered tools summarize lengthy filings, highlight key sections, and help explain complex topics such as non-GAAP measures like adjusted EBIT and adjusted earnings per diluted share that Eastman discusses in its earnings materials. Real-time updates from the SEC’s EDGAR system ensure that new EMN filings, including 10-K, 10-Q, 8-K, and Form 4 submissions, are available quickly, allowing users to review the underlying disclosures and the AI-generated insights side by side.
Insider purchase reported: Eastman Chemical Company director Kim Ann Mink purchased 1,450 shares of EMN common stock on 08/27/2025 at a price of $69.3799 per share. After the transaction she beneficially owned 2,840 shares. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025. No derivative transactions or other comments are reported in the filing.
Julie Fasone, a director of Eastman Chemical Company (EMN), purchased 1,453 shares of the company's common stock on 08/27/2025 at a reported price of $68.8 per share. After this purchase she beneficially owned 17,546 shares in a direct ownership capacity. The Form 4 was filed as a single reporting person filing and the form was signed on behalf of Ms. Fasone by Mark D. Austin by power of attorney on 08/28/2025. The report discloses no derivative transactions and provides no additional remarks.
Eric L. Butler, identified as a director of Eastman Chemical Co. (EMN), reported a purchase of 3,000 shares of Common Stock on 08/27/2025 at a price of $68.6525 per share. Following the transaction, the filing reports 9,330 shares beneficially owned, held directly. The Form 4 was signed by Power of Attorney Mark D. Austin on 08/28/2025.
Brett D. Begemann, a director of Eastman Chemical Company (EMN), reported a purchase of 1,500 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.285 per share. After the transaction, Mr. Begemann beneficially owned 9,520 shares. The Form 4 was signed on behalf of Mr. Begemann by Mark D. Austin under power of attorney on 08/28/2025.
Damon J. Audia, a director of Eastman Chemical Company (EMN), purchased 1,465 shares of common stock on 08/27/2025 at a price of $68.585 per share. After the transaction he beneficially owned 1,597 shares. The Form 4 was signed under power of attorney by Mark D. Austin on 08/28/2025. The filing reports a direct acquisition by a director and does not disclose derivative transactions.
Julie A. McAlindon, SVP, Regions & Chief Supply Chain Officer and director of Eastman Chemical Co. (EMN), purchased 2,000 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.4294 per share. After the transaction she beneficially owned 12,731 shares directly and had indirect ownership of 867 shares through an ESOP. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.
Insider purchase reported: Eastman Chemical Co. (EMN) executive Brad A. Lich purchased 3,280 shares of Common Stock on 08/27/2025 at a reported price of $68.49 per share. After the transaction, Mr. Lich beneficially owned 83,487 shares directly, plus 2,540 shares held through a 401(k) plan and 1,223 shares held through an ESOP.
Form 4 summary: William T. McLain Jr., Executive Vice President and Chief Financial Officer of Eastman Chemical Company (EMN), reported the purchase of 3,670 shares of Eastman common stock on 08/27/2025 at an average weighted price of $68.73 per share. The filing states the shares were bought at prices ranging from $68.33 to $69.16. Following the transaction, Mr. McLain beneficially owns 53,524 shares. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025. The filing discloses no derivative transactions.
Mark J. Costa, CEO and Board Chair of Eastman Chemical Company (EMN), purchased 7,400 shares of the company's common stock on 08/27/2025 at a price of $67.89 per share. After the transaction, Mr. Costa beneficially owned 453,986 shares directly and an additional 3,153 shares indirectly through an ESOP. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.
The filing records a routine insider purchase rather than a sale or derivative activity; no options, warrants, or other derivative transactions are reported. The disclosure shows the reporting person's roles as Director and CEO & Board Chair, confirming insider status and materiality for investor monitoring of executive transactions.
Capital Research Global Investors filed a Schedule 13G/A reporting beneficial ownership of 4,246,293 shares of Eastman Chemical Company common stock, representing 3.7% of the 115,459,908 shares believed outstanding. The filing lists the holder as Capital Research Global Investors, a division of Capital Research and Management Company, and provides issuer and filer addresses.
The filing certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The document is signed by Jae Won Chung on behalf of Capital Research Global Investors with a signature date of 08/05/2025.
FAQ
What is the current stock price of Eastman Chem Co (EMN)?
What is the market cap of Eastman Chem Co (EMN)?
